Amesite terminates CFO Matthew Kern, appoints Mark Corrao as CFO effective Dec 15, 2021

Amesite Inc.

Matthew Kern terminated as CFO on Dec 15, 2021; Mark Corrao appointed same day.
Corrao serves as non-employee, part-time CFO; compensation $3,000 signing + $3,000/month.
Corrao is also CFO of Neuropathix and former CFO of Generex Biotechnology and Brain Scientific.
Agreement includes indemnification and D&O insurance; term is one year, extendable by mutual consent.
Corrao remains independent CFO; company also retains The CFO Squad LLC for pre-audit and SEC compliance.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Matthew Kern

Chief Financial Officer

AMST · Amesite Inc.

Effective: 2021-12-15
Successor: Mark Corrao
Filed: December 21, 2021, 6:59 PM ET

On December 15, 2021 (the “Effective Date”), the board of directors (the “Board”) of Amesite Inc. (the “Company”) authorized and approved the termination of Matthew Kern as Chief Financial Officer of the Company, effective as of the Effective Date.

Appointed

Mark Corrao

Chief Financial Officer

AMST · Amesite Inc.

Effective: 2021-12-15
Filed: December 21, 2021, 6:59 PM ET

In addition, on December 15, 2021, in connection with the termination of Mr. Kern, the Board authorized and approved the appointment of Mark Corrao, age 64, as Chief Financial Officer of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Matthew Kern was terminated as Chief Financial Officer at Amesite Inc..

Action: terminated
Role: Chief Financial Officer

Exact text from the filing

On December 15, 2021 (the “Effective Date”), the board of directors (the “Board”) of Amesite Inc. (the “Company”) authorized and approved the termination of Matthew Kern as Chief Financial Officer of the Company, effective as of the Effective Date.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark Corrao was appointed as Chief Financial Officer at Amesite Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

In addition, on December 15, 2021, in connection with the termination of Mr. Kern, the Board authorized and approved the appointment of Mark Corrao, age 64, as Chief Financial Officer of the Company.

View on SEC.gov

Amesite Inc. filing history →

Source: SEC EDGAR

accession 0001213900-21-066698

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.